GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocMorris AG (XSWX:DOCM) » Definitions » Valuation Rank

DocMorris AG (XSWX:DOCM) Valuation Rank


View and export this data going back to 2017. Start your Free Trial

What is DocMorris AG Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


DocMorris AG Valuation Rank Related Terms

Thank you for viewing the detailed overview of DocMorris AG's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


DocMorris AG (XSWX:DOCM) Business Description

Traded in Other Exchanges
Address
Walzmuhlestrasse 60, Frauenfeld, CHE, 8500
DocMorris AG is an online pharmacy company and wholesale supplier to medical practitioners in Switzerland. The Group's reportable segments are Switzerland, Germany, and Europe. The operating segment in Switzerland comprises the wholesale business of supplying medical products to Swiss medical practitioners and the retail business that is focused on providing end consumers with drugs and health products from Zur Rose. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The operating segment Europe comprises the marketplace business of PromoFarma and Doctipharma. Majority of revenue is generated from Germany segment.